Investigating Cortical Inhibition in First-Degree Relatives and Probands in Schizophrenia

Natasha Radhu, Luis Garcia Dominguez, Tiffany A. Greenwood, Faranak Farzan, Mawahib O. Semeralul, Margaret A. Richter, Daniel M. Blumberger, Robert Chen, Paul B. Fitzgerald, Zafiris J. Daskalakis

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)


Deficits in GABAergic inhibitory neurotransmission are a reliable finding in schizophrenia (SCZ) patients. Previous studies have reported that unaffected first-degree relatives of patients with SCZ demonstrate neurophysiological abnormalities that are intermediate between probands and healthy controls. In this study, first-degree relatives of patients with SCZ and their related probands were investigated to assess frontal cortical inhibition. Long-interval cortical inhibition (LICI) was measured from the dorsolateral prefrontal cortex (DLPFC) using combined transcranial magnetic stimulation (TMS) and electroencephalography (EEG). The study presents an extended sample of 129 subjects (66 subjects have been previously reported): 19 patients with SCZ or schizoaffective disorder, 30 unaffected first-degree relatives of these SCZ patients, 13 obsessive-compulsive disorder (OCD) patients, 18 unaffected first-degree relatives of these OCD patients and 49 healthy subjects. In the DLPFC, cortical inhibition was significantly decreased in patients with SCZ compared to healthy subjects. First-degree relatives of patients with SCZ showed significantly more cortical inhibition than their SCZ probands. No differences were demonstrated between first-degree relatives of SCZ patients and healthy subjects. Taken together, these findings show that more studies are needed to establish an objective biological marker for potential diagnostic usage in severe psychiatric disorders.

Original languageEnglish
Article number43629
Number of pages11
JournalScientific Reports
Publication statusPublished - 27 Feb 2017

Cite this